EXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study)

Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01047553 ·Status: COMPLETED ·Phase: PHASE3

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo

NCT01760304 ·Status: TERMINATED ·Phase: PHASE4

Evaluate the Safety Profile of BGF MDI in Chinese Patients With COPD in Routine Clinical Practice

NCT04536402 ·Status: COMPLETED

Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease

NCT06531798 ·Status: RECRUITING ·Phase: PHASE4

Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol)

NCT05862545 ·Status: COMPLETED

Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

NCT06712563 ·Status: RECRUITING

Exacerbations and Their Outcomes International (EXACOS International)

NCT04928417 ·Status: COMPLETED

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD

NCT00824382 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising of BEA 2180 BR in Japanese Healthy Male Volunteers

NCT02254109 ·Status: COMPLETED ·Phase: PHASE1

β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation

NCT01944033 ·Status: COMPLETED ·Phase: PHASE3

Long-term Safety Study for GSK573719 in Japanese

NCT01702363 ·Status: COMPLETED ·Phase: PHASE3

Budesonide / Formoterol in Treatment of Exacerbations of COPD

NCT00239278 ·Status: COMPLETED ·Phase: PHASE2

Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation

NCT01332097 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects

NCT03159442 ·Status: COMPLETED ·Phase: PHASE1

IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US

NCT05970263 ·Status: WITHDRAWN ·Phase: PHASE4

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects

NCT00783003 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD

NCT03256552 ·Status: COMPLETED ·Phase: PHASE2

Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain.

NCT06321731 ·Status: COMPLETED

Phase I Study of GSK233705 in Healthy Japanese Male Subjects

NCT00964405 ·Status: COMPLETED ·Phase: PHASE1

PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians

NCT03859414 ·Status: COMPLETED ·Phase: PHASE1

This Study in Healthy Men Tests How Different Doses of BI 1265162 Are Taken up in the Body and How Well They Are Tolerated.

NCT03576144 ·Status: COMPLETED ·Phase: PHASE1

Early Intervention Efficacy in COPD

NCT04249310 ·Status: COMPLETED

Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients

NCT00680056 ·Status: COMPLETED ·Phase: PHASE4

Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)

NCT00269126 ·Status: COMPLETED ·Phase: PHASE3

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00422604 ·Status: COMPLETED ·Phase: PHASE2